SCHEDULE: Vanguard Discloses 5.23% Stake in Silicon Labs

Vanguard Capital Management has reported a beneficial ownership of 5.23% in Silicon Laboratories Inc. common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, now beneficially owns 1,725,524 shares of Silicon Laboratories Inc. common stock.
• This holding represents 5.23% of the class of securities.
• Vanguard Capital Management has sole dispositive power over 1,725,524 shares and sole voting power over 252,194 shares.
• The filing is made in accordance with Rule 13d-1(b) of the Securities Exchange Act of 1934, indicating Vanguard is an investment adviser.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It is a routine disclosure of institutional ownership and does not inherently signal positive or negative performance for the company.

Positives

• Vanguard's significant stake indicates confidence in Silicon Laboratories' long-term prospects.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a stable, non-activist investment approach.

Risks

• While not explicitly stated as a risk in this filing, a large institutional holder like Vanguard could potentially exert influence on corporate decisions, which may or may not align with all shareholder interests.
• The filing does not provide details on the specific Vanguard funds or clients holding these shares, making it difficult to assess the precise nature of their investment strategy or potential for future selling.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Silicon Laboratories Inc. It solely reports Vanguard's ownership stake.

Industry Context

StockSavvy.ai notes that a significant stake by a major asset manager like Vanguard in a semiconductor company like Silicon Laboratories Inc. is common and often reflects the company's position within the technology sector. Such filings are standard for institutional investors crossing ownership thresholds.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can be seen as a sign of stability or potential future influence.
• Vanguard Clients/Funds: These entities benefit from the investment performance of Silicon Laboratories Inc. through their holdings managed by Vanguard.
• Silicon Laboratories Inc. Management and Board: May need to consider the interests of a large institutional shareholder like Vanguard in strategic decision-making.

Next Steps

• Vanguard Capital Management will continue to monitor its investment in Silicon Laboratories Inc.
• Silicon Laboratories Inc. will continue its business operations and financial reporting as usual.

Key Dates

Keywords

Silicon Laboratories Inc, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Vanguard Funds